How to Clarify a Study’s Estimated Enrollment

Reviewers want to fund scientifically sound projects with the potential for great impact on health outcomes for all patients. Understand and acknowledge these expectations, then address them with the appropriate evidence to address those concerns.

You’ve designed your study in league with your community engagement and research teams. You have secured IRB approval, and you have drafted your funding proposal in collaboration with your site PIs and research team. Even with all the moving parts required for a study with human subjects, the research design has come together well.

Then you look at your estimated enrollment across study sites and stop short. They’re skewed. What to do now?

Continue reading “How to Clarify a Study’s Estimated Enrollment”

Which Style Guide Is Best for Medical Writing & Editing?

Recently, a colleague new to the field posed a question to a group of professional medical writers and editors. Briefly, she asked which style guides, in addition to the AMA Manual of Style, are worth investing (time and money) as a new medical editor.

Continue reading “Which Style Guide Is Best for Medical Writing & Editing?”

The EU’s World-Class R&D Funding and Support for Innovators

New pharma startups have more non-dilutive funding opportunities than they may realize–they just have to know where to look and open their minds.

This post has been archived.

Sometimes, US-based small startups find their evolving R&D plan, funding, or business collaborations make them suddenly ineligible for SBIR funding they had targeted. For example, clinical trial costs or even lab work would be cheaper overseas, so, just like that, eligibility slips away.

What to do? Continue reading “The EU’s World-Class R&D Funding and Support for Innovators”